EXOME

all the information, none of the junk | biotech • healthcare • life sciences

Bluebird Bio CFO Names Walsh CFO as DeTore Steps Down

Xconomy Boston — 

Cambridge, MA-based Bluebird Bio (NASDAQ: BLUE) says that chief financial officer Jim DeTore has decided to leave the company effective March 18. Starting on March 1, Jeffrey Walsh, who has been Bluebird’s chief operating officer since May 2011, will be named “chief financial and strategy officer” as well.